Long-term Outcomes of Cognitive Behavioral Therapy for Anxiety-Related Disorders

Abstract

IMPORTANCE Cognitive behavioral therapy is recommended for anxiety-related disorders, but evidence for its long-term outcome is limited. OBJECTIVE This systematic review and meta-analysis aimed to assess the long-term outcomes after cognitive behavioral therapy (compared with care as usual, relaxation, psychoeducation, pill placebo, supportive therapy, or waiting list) for anxiety disorders, posttraumatic stress disorder (PTSD), and obsessive-compulsive disorder (OCD). DATA SOURCES English-language publications were identified from PubMed, PsycINFO, Embase, Cochrane, OpenGrey (1980 to January 2019), and recent reviews. The search strategy included a combination of terms associated with anxiety disorders (eg, panic or phobi*) and study design (eg, clinical trial or randomized controlled trial). STUDY SELECTION Randomized clinical trials on posttreatment and at least 1-month follow-up effects of cognitive behavioral therapy compared with control conditions among adults with generalized anxiety disorder, panic disorder with or without agoraphobia, social anxiety disorder, specific phobia, PTSD, or OCD. DATA EXTRACTION AND SYNTHESIS Researchers independently screened records, extracted statistics, and assessed study quality. Data were pooled using a random-effects model. MAIN OUTCOMES AND MEASURES Hedges g was calculated for anxiety symptoms immediately after treatment and at 1 to 6 months, 6 to 12 months, and 12 months or more after treatment completion. RESULTS Of 69 randomized clinical trials (4118 outpatients) that were mainly of low quality, cognitive behavioral therapy compared with control conditions was associated with improved outcomes after treatment completion and at 1 to 6 months and at 6 to 12 months of follow-up for a generalized anxiety disorder (Hedges g, 0.07-0.40), panic disorder with or without agoraphobia (Hedges g, 0.22-0.35), social anxiety disorder (Hedges g, 0.34-0.60), specific phobia (Hedges g, 0.49-0.72), PTSD (Hedges g, 0.59-0.72), and OCD (Hedges g, 0.70-0.85). At a follow-up of 12 months or more, these associations were still significant for generalized anxiety disorder (Hedges g, 0.22; number of studies [k] = 10), social anxiety disorder (Hedges g, 0.42; k = 3), and PTSD (Hedges g, 0.84; k = 5), but not for panic disorder with or without agoraphobia (k = 5) and could not be calculated for specific phobia (k = 1) and OCD (k = 0). Relapse rates after 3 to 12 months were 0% to 14% but were reported in only 6 randomized clinical trials (predominantly for panic disorder with or without agoraphobia). CONCLUSIONS AND RELEVANCE The findings of this meta-analysis suggest that cognitive behavioral therapy for anxiety-related disorders is associated with improved outcomes compared with control conditions until 12 months after treatment completion. At a follow-up of 12 months or more, effects were small to medium for generalized anxiety disorder and social anxiety disorder, large for PTSD, and not significant or not available for other disorders. High-quality randomized clinical trials with 12 mont...

Cognitive behavioral group therapy for panic disorder in a general clinical setting: a prospective cohort study with 24-year follow-up

“…Our results correspond well with previous shorter-term studies on the treatment of panic disorder and agoraphobia [2,4]and with the few studies reporting long-term outcomes [9,10]. Systematic exposure treatment and cognitive therapy yield substantial and lasting therapeutic gains, and these results can be achieved in the general clinical setting.…”

Patient-Centered Care in Psoriatic Arthritis—A Perspective on Inflammation, Disease Activity, and Psychosocial Factors

“…Comprehensive reviews have shown that cognitive-behavioral therapy (CBT) is associated with surrogate measures of positive immune function: A reduction in pro-inflammatory cytokines, higher immune cell counts, natural killer cell activity, and immune outcomes [ 99 ]. CBT is a well-established intervention with long-term effects for a variety of psychiatric disorders such as major depression, generalized and social anxiety, or post-traumatic stress disorders [ 100 ]. In chronic pain conditions, systematic reviews have indicated a variety of small to moderate benefits in improving disability, catastrophizing, mood, and pain, though the significance is relevant to the study comparator (active treatment or treatment as usual) [ 101 ].…”

Relapse of anxiety‐related fear and avoidance: Conceptual analysis of treatment with acceptance and commitment therapy

“…Response rates for exposure-based cognitive behavioral therapies are approximately 50% at posttreatment and 45% at follow-up (Loerinc et al, 2015). A recent meta-analysis of long-term outcomes in cognitive behavioral therapies for anxietyrelated disorders (including but not limited to exposure therapy) showed relapse rates after 3 to 12 months ranged from 0-14% (van Dis et al, 2019). Although there is little research that has systematically examined relapse rates following exposure therapy specifically, one study showed relapse in obsessive-compulsive disorder to be as high as 50% in treatment responders over the course of a typical follow-up period of 6 months (Hiss, Foa, & Kozak, 1994).…”

“…Although there is little research that has systematically examined relapse rates following exposure therapy specifically, one study showed relapse in obsessive-compulsive disorder to be as high as 50% in treatment responders over the course of a typical follow-up period of 6 months (Hiss, Foa, & Kozak, 1994). A recent meta-analysis of long-term outcomes in cognitive behavioral therapies for anxietyrelated disorders (including but not limited to exposure therapy) showed relapse rates after 3 to 12 months ranged from 0-14% (van Dis et al, 2019). Although only six studies were included in the relapse rate analysis, these studies highlight the possibility of problematic relapse following anxiety disorder treatment.…”